One of India’s best-known whistleblowers, who exposed dangerous practices in the generic drug industry in 2013, is taking the country’s drugs regulators to court, accusing them of failing to enforce rules on drug safety in the $15 billion industry.

Read more from the source: India’s generic drugs crusader Dinesh Thakur now drags pharma regulators to court – Firstpost

Find out more about the USFDA’s laser-beam  focus on Indian pharma companies that export to the US.  Act Now